lycorine has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Baldé, AM; De Jonghe, S; Erven, K; Herrebout, WA; Le, NT; Neyts, J; Pannecouque, C; Pieters, L; Tuenter, E; Vermeyen, T | 1 |
| Boozari, M; Hosseinzadeh, H | 1 |
2 review(s) available for lycorine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies.
Topics: Amaryllidaceae Alkaloids; Antiviral Agents; Biological Products; Chemoprevention; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Phenanthridines; Phytotherapy; Plant Extracts; SARS-CoV-2; Scutellaria baicalensis; Therapies, Investigational; Virus Replication | 2021 |
1 other study(ies) available for lycorine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Anti-SARS-CoV-2 Activity and Cytotoxicity of Amaryllidaceae Alkaloids from
Topics: Amaryllidaceae; Amaryllidaceae Alkaloids; COVID-19; Liliaceae | 2023 |